The authors report five pediatric patients with acute lymphoblastic leukemia (ALL) in whom symptomatic aseptic osteonecrosis developed on therapy. All patients had been on treatment with a modified BFM protocol and developed osteonecrosis in the maintenance phase of the protocol. The avascular necro
Urolithiasis in pediatric patients with acute lymphoblastic leukemia
โ Scribed by Howard, S C; Kaplan, S D; Razzouk, B I; Rivera, G K; Sandlund, J T; Ribeiro, R C; Rubnitz, J E; Gajjar, A J; Ke, W; Hancock, M L
- Book ID
- 110055400
- Publisher
- Nature Publishing Group
- Year
- 2003
- Tongue
- English
- Weight
- 100 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0887-6924
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Endocrine complications of therapy for acute lymphoblastic leukemia (ALL) are common and are potentially debilitating both during and after therapy. Growth velocity slows during therapy for ALL, especially during the first year; however, children who do not receive cranial irradiation usually reach
## Abstract ## BACKGROUND. Dexamethasone improves the cure rate of childhood acute lymphoblastic leukemia (ALL) but causes physical and behavioral adverse events. The objective of the current study was to determine the effect of dexamethasone exposure on sleep and fatigue in pediatric patients wit
Twenty-four pediatric patients with acute lymphoblastic leukemia (ALL) on maintenance therapy were evaluated for their compliance with taking their prescribed doses of oral mercaptopurine (6-MP). Procedure and Results. We utilized the Medication Event Monitoring System (MEMS; Aprex Corporation, Fre